Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

3.62
Delayed Data
As of 3:59pm ET
 +0.09 / +2.55%
Today’s Change
2.51
Today|||52-Week Range
19.23
-72.00%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close3.53
Today’s open3.52
Day’s range3.52 - 3.74
Volume77,417
Average volume (3 months)422,737
Market cap$64.5M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)-14.11%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...+0.01+0.57%
CHMAChiasma Inc-0.17-6.46%
SCYXSCYNEXIS Inc-0.09-3.20%
TNXPTonix Pharmaceutical...-0.01-0.41%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers

Search for Jobs